Interest in Premium-Priced Nonadhesive Ventral Hernia Meshes Climbs in Latin America, According to Millennium Research Group

February 26, 2009—Waltham, Massachusetts—According to Millennium Research Group’s (MRG’s) new Latin American Markets for Hernia Repair Devices 2009 report, growing demand for premium-priced ventral hernia repair meshes will generate notable revenues over the next five years. The reduced recovery times, lower risk of infection, and lower recurrence rates that these products facilitate will cause revenues in this segment alone to surpass $20 million by 2013.

These specialized meshes are sold at a significant premium to other mesh alternatives because they are more technologically advanced, allowing them to promote faster tissue regeneration and to prevent side effects such as bowel adhesion. Because the adoption of laparoscopy, which can only be carried out using nonadhesive mesh, has historically been limited in the region, uptake of these specialized meshes has been slow. Physician training and marketing efforts are, however, having a positive effect on laparoscopic procedure volumes.

“These trends will contribute to the increasing number of laparoscopic ventral hernia repairs performed in Latin America, providing a much greater opportunity for uptake of premium-priced nonadhesive meshes than has been the case in the past,” says Lexie Code, Manager of the Endoscopy division at MRG.

MRG’s Latin American Markets for Hernia Repair Devices 2009 report provides coverage of key industry competitors, including Atrium Medical, B. Braun Aesculap, Cook Medical, Covidien, Davol (a subsidiary of C. R. Bard), ETHICON (a Johnson & Johnson company), Genzyme, W. L. Gore, and many more.